Prevalence of Anxiety Symptoms Among French General Practitioners (Psy-MG)

Mental health is a major public health issue in the general population, but few studies seem to focus on the mental health of self-employed healthcare professionals, and GPs in particular. As front-line workers who are often called upon to manage complex situations, they are quite likely to suffer from anxiety-depressive symptoms or burnout. Nevertheless, general practice is vast, and there are many different ways of practising and organising it.

Study Overview

• Status: Completed
• Conditions: Anxiety
• Intervention / Treatment: Other: Data collection

Detailed Description

The primary objective is to describe the prevalence of clinically significant anxiety symptoms in French self-employed GPs.

The secondary objective is to investigate the factors associated with the presence of clinically significant anxiety symptoms in French self-employed GPs.

• Study Type: Observational
• Enrollment (Actual): 2000

Contacts and Locations

Study Locations

• France
  • Reims, France, 51100
    • Université de Reims Champagne Ardenne

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

GPs, both qualified and established, practicing in France with at least some self-employed practice, who agreed to take part in the study.

Description

Inclusion Criteria:

• general practitioners
• qualified and established
• practicing in France
• with at least some self-employed practice
• agreeing to participate in the study

Exclusion Criteria:

• salaried general practitioners

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
GPs group; GPs, both qualified and established, practicing in France with at least some self-employed practice, who agreed to take part in the study.	Other: Data collection; Data collection

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
anxiety	Anxiety will be evaluated using the Scale Trait Anxiety Inventory version Y (STAI-Y-A). The STAI Form Y-A consists of a set of twenty item sonly focus on the psychological and not the somatic aspects of anxiety. The STAI Form Y-A is a self-reported questionnaire. Each item is scored from 1 to 4 and a sum score of all items is computed. Higher score indicates greater anxiety. Presence of anxiety will be defined by a score greater than or equal to 46.	Day 0

Collaborators and Investigators

• Sponsor: Université de Reims Champagne-Ardenne

Study record dates

Study Major Dates

• Study Start (Actual): May 1, 2024
• Primary Completion (Actual): July 1, 2024
• Study Completion (Actual): December 1, 2024

Study Registration Dates

• First Submitted: January 8, 2025
• First Submitted That Met QC Criteria: January 8, 2025
• First Posted (Actual): March 25, 2025

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: January 8, 2025
• Last Verified: January 1, 2025

More Information

Terms related to this study

• Keywords: anxiety; prevalence; self-employed GPs
• Additional Relevant MeSH Terms: Mental Disorders; Anxiety Disorders
• Other Study ID Numbers: 2024_RIPH_02_Psy-MG

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No